Davis Polk Reps Oracle In $685M Phase Forward Deal
Technology giant Oracle Corp. announced Friday that it would acquire medical clinical research software developer Phase Forward Inc. for $17 per share, or approximately $685 million....To view the full article, register now.
Already a subscriber? Click here to view full article